Pharmaceutical Giants Report Major Breakthroughs in Aggressive Breast Cancer Treatment
** New clinical trial data presented at a major medical oncology conference reveals substantial progress in treating triple-negative breast cancer. Pharmaceutical companies report their therapies have significantly improved survival rates and delayed disease progression in patients with this challenging cancer subtype. **CONTENT:**